Literature DB >> 34900468

Cytomegalovirus-Induced Pericarditis, Pulmonary Embolism, and Transaminitis in an Immunocompetent Patient.

Waiz Wasey1, Navpreet Badesha2, Maria Rossi2, Caitlin Carter3, Samantha Bibee2.   

Abstract

Cytomegalovirus (CMV) is a global virus with a high prevalence that usually manifests in immunocompromised patients, with significant morbidity and mortality. Though fairly common in immunocompetent patients admitted in the intensive care units, the infection is usually subclinical. Healthy individuals either have a subclinical course or exhibit a mild mononucleosis-like syndrome. Due to this, little attention has been given to morbidity and mortality that CMV infection may lead to in immunocompetent patients. We report a case of a 55-year-old immunocompetent female with no significant history who was admitted to our medical service with pericarditis, complicated by a right pulmonary embolism. Infectious workup revealed CMV as the cause for the presenting symptoms.
Copyright © 2021, Wasey et al.

Entities:  

Keywords:  cytomegalovirus; pericarditis; pulmonary embolism; transaminitis; viral infection

Year:  2021        PMID: 34900468      PMCID: PMC8648299          DOI: 10.7759/cureus.19285

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  13 in total

Review 1.  Splenic infarction due to cytomegalovirus infection in an immunocompetent patient.

Authors:  Amaia Redondo; Vanesa Jarne; Miren Arteaga
Journal:  Med Clin (Barc)       Date:  2018-11-27       Impact factor: 1.725

2.  Cytomegalovirus infection in an immunocompetent patient.

Authors:  Yu Jun Wong
Journal:  Gastrointest Endosc       Date:  2018-12       Impact factor: 9.427

3.  [Cytomegalovirus infection in immunocompetent patients. Clinical and immunological considerations].

Authors:  Claudia Colomba; Francesco Lalicata; Lucia Siracusa; Laura Saporito; Danilo Di Bona; Giovanni Giammanco; Simona De Grazia; Lucina Titone
Journal:  Infez Med       Date:  2012-03

4.  Seroprevalence of cytomegalovirus infection in the United States, 1988-1994.

Authors:  Stephanie A S Staras; Sheila C Dollard; Kay W Radford; W Dana Flanders; Robert F Pass; Michael J Cannon
Journal:  Clin Infect Dis       Date:  2006-10-02       Impact factor: 9.079

Review 5.  Thrombosis associated with acute cytomegalovirus infection: a meta-analysis.

Authors:  Dan Justo; Talya Finn; Lihi Atzmony; Noam Guy; Arie Steinvil
Journal:  Eur J Intern Med       Date:  2010-12-16       Impact factor: 4.487

Review 6.  Cytomegalovirus.

Authors:  M Veronica Dioverti; Raymund R Razonable
Journal:  Microbiol Spectr       Date:  2016-08

Review 7.  Cytomegalovirus-associated splanchnic vein thrombosis in immunocompetent patients: A systematic review.

Authors:  Michele Bertoni; Alessandro Squizzato; Marina Foretic; Samanta Zanieri; Massimo Edoardo Di Natale
Journal:  Thromb Res       Date:  2018-06-21       Impact factor: 3.944

Review 8.  Venous Thromboembolism: Advances in Diagnosis and Treatment.

Authors:  Tobias Tritschler; Noémie Kraaijpoel; Grégoire Le Gal; Philip S Wells
Journal:  JAMA       Date:  2018-10-16       Impact factor: 56.272

Review 9.  Risk factors of venous thrombo-embolism during cytomegalovirus infection in immunocompetent individuals. A systematic review.

Authors:  Manuela Ceccarelli; Emmanuele Venanzi Rullo; Giuseppe Nunnari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-18       Impact factor: 5.103

Review 10.  Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review.

Authors:  Petros I Rafailidis; Eleni G Mourtzoukou; Ioannis C Varbobitis; Matthew E Falagas
Journal:  Virol J       Date:  2008-03-27       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.